GlassScriptPhysician profile
John J Wrenn
NPI 1659372019
$5,750.82
in general payments reported to CMS, 2019-2025
40 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $87.09 · 2021: $325 · 2022: $1,358 · 2023: $1,418 · 2024: $803 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,406.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $813.57 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $649.82 | 2019-2025 | Erleada, Balversa |
| Pfizer INC. | $580.16 | 2019-2025 | |
| Procept Biorobotics Corporation | $441.46 | 2023 | Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $418.45 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $387.12 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $330.60 | 2019-2025 | Botox, Lupron Depot |
| Merck Sharp & Dohme LLC | $320.12 | 2023-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Urogen Pharma, INC. | $287.33 | 2022-2025 | Jelmyto |
| Myovant Sciences INC. | $260.86 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $180.86 | 2019-2025 | |
| Blue Earth Diagnostics | $111.28 | 2019-2022 | |
| Urovant Sciences INC | $101.85 | 2022 | |
| Novartis Pharmaceuticals Corporation | $100.65 | 2025 | |
| Teleflex LLC | $96.60 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $75.59 | 2019-2025 | Xyosted |
| Astrazeneca Pharmaceuticals LP | $73.66 | 2025 | Lynparza |
| Amgen INC. | $42.76 | 2019-2022 | |
| Immunitybio, INC. | $42.46 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $39.10 | 2024-2025 | Eclipse, Optilume Bph Drug Coated Balloon Catheter |
| E.R. Squibb & Sons, L.L.C. | $38.73 | 2022-2025 | Opdivo |
| Accord Healthcare, INC. | $38.27 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $33.67 | 2024-2025 | Adstiladrin |
| Travere Therapeutics, INC. | $30.50 | 2019 | |
| Tempus Ai, INC | $29.36 | 2025 | Xt Cdx |
| Endo Pharmaceuticals INC. | $27.70 | 2022 | |
| Progenics Pharmaceuticals, INC. | $26.46 | 2025 | |
| Coloplast Corp | $21.02 | 2025 | |
| Cycle Pharmaceuticals INC | $20.60 | 2025 | Venxxiva |
| Vertex Pharmaceuticals Incorporated | $20.36 | 2025 | |
| Sun Pharmaceutical Industries INC. | $19.67 | 2022 | |
| Olympus America INC. | $18.82 | 2024 | Itind System |
| Halozyme INC | $16.55 | 2023 | |
| Alnylam Pharmaceuticals INC. | $14.77 | 2025 | Givlaari |
| Foundation Medicine, INC. | $14.31 | 2023 | |
| Calyxo, INC. | $14.04 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $11.69 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wrenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.